← All Investors
ARRIVENT BIOPHARMA INC
AVBP
Holders
5
Combined Value
$36M
Combined Shares
1,565,399
Current Price
$31.36
52W High
$33.62
vs 52W High
−6.7%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Steve Cohen - Point72 | $17M | 0.02% | ~$22.22 | +41.2% | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $9M | 0.00% | ~$20.74 | +51.2% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $8M | 0.00% | ~$20.12 | +55.9% | Sold Q1 2026 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $509K | 0.00% | ~$23.07 | +35.9% | Bought Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $367K | 0.00% | ~$22.13 | +41.7% | Bought Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 5 | 1,565,399 | +61.6% | $36M | $23.07 |
| Q4 2025 | 4 | 968,589 | +34.7% | $19M | $20.12 |
| Q3 2025 | 3 | 719,205 | +11.4% | $13M | $18.45 |
| Q2 2025 | 4 | 645,438 | +272.3% | $14M | $21.77 |
| Q1 2025 | 2 | 173,351 | +182.3% | $3M | $18.49 |
| Q4 2024 | 2 | 61,413 | −72.7% | $1M | $26.64 |
| Q3 2024 | 2 | 225,287 | +1761.4% | $5M | $23.50 |
| Q2 2024 | 1 | 12,103 | — | $224K | $18.55 |